510(k) Report

510(k) · Cleared

Cleared

Vecttor VT-300

K231575510(k) AbbreviatedCleared Feb 8, 2024253-day reviewClass II21 CFR 882.5890

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Artaflex, Inc. · LIH Interferential Current Therapy

Cleared on Feb 8, 2024 as substantially equivalent to K121662 (Alan Neuromedical Technologies, LLC, 2012) after a 253-day review. Its family tree reaches back 2 generations to 2001.

Decided
Feb 8, 2024
Review
253 days
Class
Class II
Product code
LIH
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K010565 (2001). No later device cites it as a predicate yet.

  1. Root · 2 generations backK010565 Dynatron STSDynatronics Corp. · 2001
  2. 1 generation backK121662 Vecttor VT-200Alan Neuromedical Technologies, LLC · 2012
  3. This deviceK231575 Vecttor VT-300Artaflex, Inc. · 2024
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K010565Dynatron STSDynatronics Corp.2001—
−1K121662Vecttor VT-200Alan Neuromedical Technologies, LLC2012—
0 (this device)K231575Vecttor VT-300Artaflex, Inc.2024—
FIG. 1 — Lineage of K231575, 2001–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LIH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K121662Vecttor VT-200
Summary page 4
…Classification Name: Interferential Current Therapy Product Code: LIH Identification of the legally marketed device to which the submitter claims equivalence. K121662 VECTTOR VT-200 Description of the device VT-300 device is portable and battery operated. VT-300 Device is comprised of a PC…
Alan Neuromedical Technologies, LLC2012—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 23 years and passes through 3 companies; a new generation was cleared every 11.5 years on median.
  • None of the 2 ancestors has a recall.

How does its category compare?

All LIH devices

LIH Interferential Current Therapy: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · LIH

1in 2024

2007: 12009: 22010: 22011: 12012: 22019: 12021: 12024: 1
2007high 2 (2009) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LIH

Too few LIH 510(k)s in any year since 2007 to give a median.

Recalls per year · LIH

No recall names LIH since 2007.

Adverse event reports per year · LIH

1in 2025

2008: 142009: 32010: 22011: 12012: 12013: 12015: 12016: 12017: 12019: 12021: 12024: 12025: 1
2007high 14 (2008) · low 0 (2007)2025

MAUDE reports naming product code LIH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—014
20092—03
20102—02
20111—01
20122—01
20130—01
20140—00
20150—01
20160—01
20170—01
20180—00
20191—01
20200—00
20211—01
20220—00
20230—00
20241—01
20250—01
20260—0—

What is it indicated for?

Electrical stimulation delivered by the device is intended for the symptomatic relief of chronic intractable pain and/or management of post-traumatic or post-surgical pain.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K231575: Vecttor VT-300.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K231575

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026